C70.0 - Malignant neoplasm of cerebral meninges

Version 2023
ICD-10:C70.0
Short Description:Malignant neoplasm of cerebral meninges
Long Description:Malignant neoplasm of cerebral meninges
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
      • Malignant neoplasm of meninges (C70)

C70.0 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of cerebral meninges. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic arachnoid cerebral ; Neoplasm, neoplastic brain NEC meninges ; Neoplasm, neoplastic cerebrum, cerebra (cortex) (hemisphere) (white matter) meninges ; Neoplasm, neoplastic cranial (fossa, any) meninges ; Neoplasm, neoplastic dura (cranial) (mater) cerebral ; Neoplasm, neoplastic falx (cerebella) (cerebri) ; Neoplasm, neoplastic meninges brain ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Clinical Information

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C70.0192.1 - Mal neo cerebral mening
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »arachnoid
    »cerebral
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »brain NEC
    »meninges
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »cerebrum, cerebra (cortex) (hemisphere) (white matter)
    »meninges
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »cranial (fossa, any)
    »meninges
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »dura (cranial) (mater)
    »cerebral
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »falx (cerebella) (cerebri)
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »meninges
    »brain
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »meninges
    »cerebral
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »meninges
    »crainial
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »meninges
    »intracranial
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »pia mater
    »cerebral
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »pia mater
    »cranial
C70.0C79.32D32.0D42.0D49.7
»Neoplasm, neoplastic
  »tentorium (cerebelli)
C70.0C79.32D32.0D42.0D49.7

Patient Education


Brain Tumors

A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain.

Brain tumors can cause many symptoms. Some of the most common are:

Doctors diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT scan, and biopsy. Treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. Targeted therapy uses drugs or other substances that attack cancer cells with less harm to normal cells. Many people get a combination of treatments.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Brain Tumors-Patient Version

Learn about brain and spinal cord tumor risk factors, symptoms, tests to diagnose, factors affecting prognosis, and treatment.
[Learn More in MedlinePlus]

Code History